Johnson & Johnson CEO Alex Gorsky on awaiting the FDA’s authorization of his company’s single-dose COVID-19 vaccine, efforts to update the vaccine in response to new variants, and ramping up production to deliver 100 million doses to the U.S. when the time comes. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
